Organocatalytic enantioselective indole alkylations of α,β-unsaturated ketones

Wei Chen a, Wei Du a, Lei Yue a, Rui Li b, Yong Wu a, Li-Sheng Ding b and Ying-Chun Chen *ac
aKey Laboratory of Drug-Targeting of Education Ministry and Department of Medicinal Chemistry, West China School of Pharmacy, Sichuan University, Chengdu, 610041, China. E-mail: ycchenhuaxi@yahoo.com.cn; Fax: +86 28 85502609; Tel: +86 28 85502609
bChengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, 610041, China
cState Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, China

Received 13th November 2006 , Accepted 3rd January 2007

First published on 19th January 2007


Abstract

The C3-selective enantioselective Michael-type Friedel–Crafts alkylations of indoles with nonchelating α,β-unsaturated alkyl ketones, catalysed by a chiral primary amine derived from natural cinchonine, were investigated. The reactions, in the presence of 30 mol% catalyst, were smoothly conducted at 0 to −20 °C. Moderate to good ee (47–89%) has been achieved.


Introduction

The Friedel–Crafts reaction and its enantioselective variants have been employed as a powerful carbon–carbon bond forming process.1 The application of the reaction to the alkylations of indoles triggered special interest because the indole framework has been widely identified in a large amount of natural products and medicinal agents.2 Although numerous acid-catalysed Michael-type additions of electron-rich indoles to α,β-unsaturated carbonyl compounds have been reported, the asymmetric process has been less explored.3 Previous examples utilised oxazoline-based metal complexes as the chiral catalysts, and high enantioselectivity has been achieved for the Michael acceptors with bidentate structures.4 However, only one example has been presented with nonchelating α,β-unsaturated aryl ketones (up to 89% ee) catalysed by a chiral [Al(salen)Cl] complex, and very low ee (11%) was obtained for simple α,β-unsaturated alkyl ketones.5 On the other hand, MacMillan et al. developed a versatile protocol for the asymmetric Michael-type Friedel–Crafts reactions between various aromatic compounds and α,β-unsaturated aldehydes, employing benzyl imidazolidinone salts derived from L-phenylalanine as the LUMO-lowering activation organocatalysts.6,7 Nevertheless, such a catalytic system was inefficient for the stereoselective addition of indoles to α,β-unsaturated ketones, and poor ee (25%) has been observed.8 Therefore, the development of alternative catalysts for the enantioselective Friedel–Crafts reactions between indoles and simple α,β-unsaturated ketones is highly desirable.

During our continuing studies on organocatalysis based on the iminium strategy,9 we are interested in the undeveloped asymmetric reaction between indoles and α,β-unsaturated ketones catalysed by chiral aminocatalysts.10 However, we found that a very sluggish activating rate, or even inert capacity was generally observed for secondary amines which we have successfully applied in the reactions of α,β-unsaturated aldehydes. We realised that the formation of the iminium cation between the α,β-unsaturated ketone and a secondary amine would be relatively unfavoured because of steric hindrance. It could be envisaged that the generation of a ketimine cation from a primary amine salt and the ketone carbonyl should be much more practicable. Thus the LUMO energy of the α,β-unsaturated system could be lowered, and the Michael-type coupling reaction would be facilitated [eqn (1)].11

 
ugraphic, filename = b616504d-u1.gif(1)

Results and discussion

Inspired by this initiative, primary amines 1a–1d with various chiral scaffolds (Fig. 1) were screened in the reaction of indole 2a and α,β-unsaturated ketone 3a in the presence of acidic additive. Amino alcohol 1a was inert for the coupling reaction (Table 1, entry 1), and the desired C3-selective Friedel–Crafts alkylation product 4aa was obtained in a racemic form with alanamide 1b12 (entry 2). Gratifyingly, we found that the diamine compound 1c derived from natural cinchonine13 showed promising catalytic activity in the combination with 2 equiv. of CF3SO3H, and 4aa was cleanly obtained in 26% isolated yield with 56% ee after 12 h at ambient temperature, while a large amount of starting materials remained unchanged in this period of time (entry 3). A lower ee was attained in the presence of 9-amino-9-deoxyepiquinine 1d13 (entry 4). Subsequently, a range of reaction conditions with diamine 1c were further investigated in order to improve the catalytic efficacy. HClO4 salt gave faster reaction but the ee was much lower (entry 5). p-TsOH salt was less efficient (entry 6) and TFA salt showed almost no catalytic activity (entry 7). Although slow reaction was observed in pure DCM catalysed by 1c–(CF3SO3H)2 (entry 8), it was found that adding 15% i-PrOH (v/v) could accelerate the reaction (entry 9).6b However, the ee was decreased in the mixture of THF–i-PrOH (entry 10). Excellent yield was obtained in the mixture of DCMMeOH but the ee was disappointing (entry 11). Finally we conducted the Friedel–Crafts alkylation at lower temperature. The reaction became sluggish with 10 mol% of 1c at −10 °C, 65% ee with 52% yield was obtained after 6 days (entry 12). Nevertheless, up to 75% ee with better yield was achieved catalysed by 30 mol% of 1c at −20 °C (entry 13).14
Structures of the chiral primary amine catalysts.
Fig. 1 Structures of the chiral primary amine catalysts.
Table 1 Screening studies of the asymmetric Friedel–Crafts reaction of indole 2a and α,β-unsaturated ketone 3aa
ugraphic, filename = b616504d-u2.gif
Entry Catalyst Solvent Additive Yieldb (%) Eec (%)
a Unless otherwise noted, the reaction was conducted with 2a (0.1 mmol), 3a (0.2 mmol), catalyst 1 (0.01 mmol) and acidic additive (0.02 mmol) in a solvent (1 mL) at room temperature for 12 h. b Isolated yield. c Determined by chiral HPLC analysis. d Adding 0.01 mmol of CF3SO3H. e At −10 °C for 6 d. f At −20 °C with 30 mol% of 1c for 6d.
1d 1a THF CF3SO3H
2d 1b THF CF3SO3H 30 0
3 1c THF CF3SO3H 26 56
4 1d THF CF3SO3H 35 35
5 1c THF HClO4 60 22
6 1c THF p-TsOH 13 58
7 1c THF CF3COOH Trace
8 1c DCM CF3SO3H 13 51
9 1c DCMi-PrOH CF3SO3H 44 58
10 1c THF–i-PrOH CF3SO3H 44 36
11 1c DCMMeOH CF3SO3H 99 26
12e 1c DCMi-PrOH CF3SO3H 52 65
13f 1c DCMi-PrOH CF3SO3H 70 75


With the reaction conditions in hand, we then examined the scope and limitations of enantioselective indole alkylations catalysed by 30 mol% of 1c. The reaction results are summarised in Table 2. Lower reactivity was observed in the reaction of indole 2a with unsaturated ketone 3b with a branched β-substitution while a good ee (82%) was obtained (entry 2). The alkylation reactions with β-aryl unsaturated ketones 3c and 3d were conducted at 0 °C, and moderate ee was observed (entries 3 and 4). A much higher ee was achieved in the reaction of indole 2a and ethyl enone 3e (entry 5). On the other hand, 5-methoxyindole 2b generally gave higher enantioselectivity in the Friedel–Crafts reactions with various α,β-unsaturated ketones. The coupling reactions with alkyl-substituted substrates 3a and 3b were sluggish but good ees were achieved (entries 6–9). In contrast, high reactivity was noted for β-aryl enone 3d with moderate enantioselectivity (entries 10 and 11). Much lower ees were obtained for enones 3f and 3g with electron-donating substitution (entries 12 and 13). High ees were attained for β-aryl enones 3e, 3h and 3i with bulkier alkyl group at 0 °C (entries 14–17), but lower reactivity was observed for enone 3h (entry 16). The ee was moderate in the case of cyclic enone 3j (entry 18). The enantioselectivity also decreased when indole 2c with an electron-withdrawing substitution was applied. In addition, we explored the asymmetric Friedel–Crafts reaction of 2-methylindole 2d. Interestingly, better reactivity was observed in the reaction with β-alkyl enones compared with indole 2a, and good ee was obtained using enone 3b as the acceptor (entries 20 and 21).

Table 2 Asymmetric Friedel–Crafts alkylations of indoles 2 with α,β-unsaturated ketone 3a
ugraphic, filename = b616504d-u3.gif
Entry 2 R2 R3 (3) T (°C)/t (d) 4 Yieldb (%) Eec (%)
a Reaction conditions: 2 (0.1 mmol), 3 (0.2 mmol), catalyst 1c (0.03 mmol) and CF3SO3H (0.06 mmol) were stirred in DCMi-PrOH (85 : 15, 1 mL). b Isolated yield. c Determined by chiral HPLC analysis. d The absolute configuration was determined to be (R) by X-ray analysis, and the other products were assigned accordingly.
1 2a n-Pr CH3 (3a) −20/6 4aa 70 75
2 2a i-Pr CH3 (3b) −10/6 4ab 35 82
3 2a Ph CH3 (3c) 0/3 4ac 72 65
4 2a p-Cl-Ph CH3 (3d) 0/3 4ad 61 64
5 2a Ph C2H5 (3e) 0/6 4ae 47 81
6 2b n-Pr CH3 (3a) −10/6 4ba 74 78
7       −20/6   43 84
8 2b i-Pr CH3 (3b) 0/4 4bb 42 81
9       −20/6   23 86
10 2b p-Cl-Ph CH3 (3d) 0/2 4bd 99 70
11       −20/6   70 72
12 2b p-MeO-Ph CH3 (3f) 0/7 4bf 93 47
13 2b 2-Thienyl CH3 (3g) 0/7 4bg 83 50
14 2b Ph C2H5 (3e) 0/3 4be 91 85
15       −20/6   16 89
16 2b p-Cl-Ph C2H5 (3h) 0/7 4bh 41 88d
17 2b Ph C3H7 (3i) 0/5 4bi 78 87
18 2b –C3H6 (3j) −20/8 4bj 82 56
19 2c n-Pr CH3 (3a) 0/6 4ca 72 59
20 2d n-Pr CH3 (3a) −20/6 4da 99 65
21 2d i-Pr CH3 (3b) −20/6 4db 78 82


In order to determine the absolute configuration of the Friedel–Crafts products, single crystals suitable for X-ray crystallographic analysis were obtained from compound 4bh bearing a chlorine atom. Over 99% ee could be gained after two recrystallizations of 4bh (88% ee) from a mixture of ethyl acetate and hexane. The absolute configuration of 4bh was determined to be (R) in the benzylic carbon (Fig. 2). Subsequently, we proposed a possible transitional model for the stereocontrol. As illustrated in Fig. 3, the ketimine cation between 1c and α,β-unsaturated ketone 3h might adopt a trans-conformation. Then nucleophilic attack from re-face of the iminium ion would give the desired (R)-product.15


X-Ray structure of enantiopure 4bh. Thermal ellipsoids are shown at 30% probability.
Fig. 2 X-Ray structure of enantiopure 4bh. Thermal ellipsoids are shown at 30% probability.

Plausible iminium ion in the asymmetric Friedel–Crafts reaction.
Fig. 3 Plausible iminium ion in the asymmetric Friedel–Crafts reaction.

Conclusions

In conclusion, we have demonstrated for the first time that a chiral primary amine derived from natural cinchonine was an efficient organocatalyst for the asymmetric Michael-type Friedel–Crafts alkylations of indoles and α,β-unsaturated alkyl ketones. Moderate to high enantioselectivity (47–89% ee) has been achieved. To our knowledge, this is the best result for this type of reactions in the limited literature reports. Further expansion of the asymmetric Friedel–Crafts reactions, mechanistic studies and application of the readily available and inexpensive primary aminocatalysts in other environmentally benign stereoselective reactions are actively under way in our laboratory.16

Experimental

General methods

TLC was performed on glass-backed silica plates. Column chromatography was performed using silica gel (200–300 mesh) eluting with ethyl acetate and petroleum ether. NMR was recorded on Bruker 300 or 400 MHz spectrometers. Chemical shifts were reported in ppm down field from tetramethylsilane with the solvent resonance as the internal standard. ESI HRMS was recorded on a Bruker Apex-2. Enantiomeric excess was determined by HPLC analysis on Chiralpak columns. All other reagents were used without purification as commercially available.

General procedure for Friedel–Crafts alkylations of indoles with α,β-unsaturated ketones

α,β-Unsaturated ketones 3 (0.2 mmol), indole 2 (0.1 mmol) and catalyst 1c 8.8 mg (0.03 mmol) were stirred in a mixture of DCM and i-PrOH (85 : 15, v/v, 1.0 mL) at the desired temperature. Then CF3SO3H 5.3 µL (0.06 mmol) was added. The reaction was maintained at this temperature and monitored by TLC analysis. Then the solution was diluted with Et2O (10 mL), washed with water, dried, and concentrated. The residue was chromatographed on silica gel to give the desired product 4.
4-(1H-Indol-3-yl)heptan-2-one (4aa). 70% yield. [α]20D +11.0 (c = 0.22, CH2Cl2), 75% ee. The enantiomeric excess was determined by HPLC on Chiralpak AS column (5% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 23.69 min, tmajor = 26.28 min. 1H NMR (400 MHz, CDCl3): δ = 8.03 (br s, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 7.20–7.07 (m, 2H), 6.95 (d, J = 2.4 Hz, 1H), 3.50–3.44 (m, 1H), 2.89 (dd, J = 15.6, 7.6 Hz, 1H), 2.79 (dd, J = 15.8, 7.2 Hz, 1H), 2.02 (s, 3H), 1.78–1.62 (m, 2H), 1.31–1.21 (m, 2H), 0.85 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 208.9, 136.5, 126.5, 121.9, 121.2, 119.3, 119.2, 119.0, 111.2, 50.2, 38.1, 32.6, 30.4, 20.7, 14.0. ESI HRMS: calcd. for C15H19NO + Na 252.1364, found 252.1356.
4-(1H-Indol-3-yl)-5-methylhexan-2-one (4ab). 35% yield. [α]20D +5.0 (c = 0.16, CH2Cl2), 82% ee. The enantiomeric excess was determined by HPLC on Chiralpak AS column (5% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 25.40 min, tmajor = 34.18 min. 1H NMR (400 MHz, CDCl3): δ = 8.07 (br s, 1H), 7.65 (d, J = 8.0 Hz, 1H), 7.34 (d, J = 8.0 Hz, 1H), 7.18 (t, J = 7.2 Hz, 1H), 7.11 (d, J = 7.2 Hz, 1H), 6.93 (d, J = 2.0 Hz, 1H), 3.37–3.31 (m, 1H), 2.93–2.81 (m, 2H), 2.09–2.02 (m, 1H), 1.98 (s, 3H), 0.93 (d, J = 6.8 Hz, 3H), 0.87 (d, J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.3, 136.3, 127.2, 121.9, 121.8, 119.4, 119.1, 117.5, 111.1, 47.0, 39.3, 32.6, 30.1, 20.5, 20.4. ESI HRMS: calcd. for C15H19NO + Na 252.1364, found 252.1351.
4-(1H-Indol-3-yl)-4-phenylbutan-2-one (4ac). 72% yield. [α]20D −25.3 (c = 0.4, CH2Cl2), 65% ee. The enantiomeric excess was determined by HPLC on Chiralpak AS column (30% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 8.15 min, tmajor = 7.37 min. 1H NMR (400 MHz, CDCl3): δ = 8.02 (br s, 1H), 7.42 (d, J = 8.0 Hz, 1H), 7.33–6.98 (m, 9H), 4.83 (t, J = 7.6 Hz, 1H), 3.25 (dd, J = 16.2, 7.6 Hz, 1H), 3.16 (dd, J = 16.0, 8.0 Hz, 1H), 2.08 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 207.9, 143.9, 136.5, 128.4, 127.6, 126.3, 122.0, 121.3, 119.3, 118.5, 111.1, 50.2, 38.3, 30.3. ESI HRMS: calcd. for C18H17NO + Na 286.1208, found 286.1191.
4-(4-Chlorophenyl)-4-(1H-indol-3-yl)butan-2-one (4ad). 61% yield. [α]20D −12.2 (c = 0.36, CH2Cl2), 64% ee. The enantiomeric excess was determined by HPLC on Chiralpak AS column (30% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 7.81 min, tmajor = 6.82 min. 1H NMR (400 MHz, CDCl3): δ = 8.04 (br s, 1H), 7.38–7.32 (m, 2H), 7.25–7.14 (m, 5H), 7.05–6.97 (m, 2H), 4.81 (t, J = 7.6 Hz, 1H), 3.24 (dd, J = 16.2, 7.2 Hz, 1H), 3.13 (dd, J = 16.4, 8.0 Hz, 1H), 2.09 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 207.2, 142.5, 136.6, 132.0, 129.1, 128.6, 126.3, 122.3, 121.3, 119.5, 119.3, 118.4, 111.2 50.0, 37.6, 30.4. ESI HRMS: calcd. for C18H16ClNO + Na 320.0818, found 320.0813.
1-(1H-Indol-3-yl)-1-phenylpentan-3-one (4ae). 47% yield. [α]20D −18.6 (c = 0.22, CH2Cl2), 81% ee. The enantiomeric excess was determined by HPLC on Chiralpak AS column (30% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 6.60 min, tmajor = 5.69 min. 1H NMR (400 MHz, CDCl3): δ = 8.01 (br s, 1H), 7.42 (d, J = 8.8 Hz, 1H), 7.33–7.23 (m, 5H), 7.18–7.12 (m, 2H), 7.03–6.98 (m, 2H), 4.85 (t, J = 7.6 Hz, 1H), 3.23 (dd, J = 15.8, 7.6 Hz, 1H), 3.14 (dd, J = 15.8, 8.0 Hz, 1H), 2.43–2.24 (m, 2H), 0.94 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 210.2, 144.0, 136.6, 128.4, 127.7, 126.5, 126.3, 122.1, 121.3, 119.5, 119.4, 119.0, 111.1, 49.1, 38.4, 36.4, 7.5. ESI HRMS: calcd. for C19H19NO + Na 300.1364, found 300.1349.
4-(5-Methoxy-1H-indol-3-yl)heptan-2-one (4ba). 43% yield. [α]20D +8.6 (c = 0.36, CH2Cl2), 84% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 13.21 min, tmajor = 11.75 min. 1H NMR (400 MHz, CDCl3): δ = 7.94 (br s, 1H), 7.23 (d, J = 8.4 Hz, 1H), 7.09 (d, J = 2.8 Hz, 1H), 6.94 (d, J = 2.4 Hz, 1H), 6.85 (dd, J = 8.4, 2.4 Hz, 1H), 3.88 (s, 3H), 3.48–3.41 (m, 1H), 2.87 (dd, J = 15.8, 7.2 Hz, 1H), 2.78 (dd, J = 16.0, 6.8 Hz, 1H), 2.04 (s, 3H), 1.78–1.62 (m, 2H), 1.36–1.23 (m, 2H), 0.87 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 208.9, 153.7, 131.7, 127.0, 121.9, 118.8, 111.8, 111.7, 101.5, 56.0, 50.1, 38.0, 32.4, 30.5, 20.7, 14.1. ESI HRMS: calcd. for C16H21NO2 + Na 282.1470, found 282.1454.
4-(5-Methoxy-1H-indol-3-yl)-5-methylhexan-2-one (4bb). 23% yield. [α]20D −6.0 (c = 0.25, CH2Cl2), 86% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 12.08 min, tmajor = 13.07 min. 1H NMR (400 MHz, CDCl3): δ = 8.06 (br s, 1H), 7.22 (d, J = 8.8 Hz, 1H), 7.08 (d, J = 2.0 Hz, 1H), 6.90 (d, J = 2.0 Hz, 1H), 6.84 (dd, J = 2.0, 9.0 Hz, 1H), 3.87 (s, 3H), 3.32–3.27 (m, 1H), 2.90–2.81 (m, 2H), 2.08–2.01 (m, 1H), 1.99 (s, 3H), 0.92 (d, J = 6.8 Hz, 3H), 0.88 (d, J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.5, 153.7, 131.5, 127.6, 122.7, 117.2, 111.7, 111.6, 101.6, 55.9, 46.9, 39.2, 32.6, 30.1, 20.5, 20.3. ESI HRMS: calcd. for C16H21NO2 + Na 282.1470, found 282.1457.
4-(4-Chlorophenyl)-4-(5-methoxy-1H-indol-3-yl)butan-2-one (4bd). 70% yield. [α]20D +20.6 (c = 0.66, CH2Cl2), 72% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 32.58 min, tmajor = 20.86 min. 1H NMR (400 MHz, CDCl3): δ = 8.02 (br s, 1H), 7.22–7.17 (m, 5H), 6.92 (d, J = 2.0 Hz, 1H), 6.81 (dd, J = 8.6, 2.4 Hz, 1H), 6.77 (d, J = 2.4 Hz, 1H), 4.75 (t, J = 7.6 Hz, 3H), 3.74 (s, 3H), 3.21 (dd, J = 16.2, 7.2 Hz, 1H), 3.11 (dd, J = 16.0, 8.0 Hz, 1H), 2.08 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 207.3, 153.8, 142.5, 132.0, 131.7, 129.1, 128.5, 126.7, 122.0, 118.0, 112.2, 111.9, 101.3, 55.8, 49.9, 37.5, 30.4. ESI HRMS: calcd. for C19H18ClNO2 + Na 350.0924, found 350.0914.
4-(5-Methoxy-1H-indol-3-yl)-4-(4-methoxyphenyl)butan-2-one (4bf). 93% yield. [α]20D +8.3 (c = 0.6, CH2Cl2), 47% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (15% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 27.20 min, tmajor = 20.76 min. 1H NMR (400 MHz, CDCl3): δ = 7.99 (br s, 1H), 7.23–7.16 (m, 4H), 6.92 (d, J = 2.4 Hz, 1H), 6.83–6.78 (m, 3H), 4.72 (t, J = 7.6 Hz, 3H), 3.74 (s, 6H), 3.19 (dd, J = 15.8, 7.2 Hz, 1H), 3.11 (dd, J = 16.0, 8.0 Hz, 1H), 2.07 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 207.9, 157.9, 153.7, 136.0, 131.7, 128.6, 126.9, 121.9, 118.8, 113.8, 112.0, 111.8, 101.5, 55.8, 55.2, 50.4, 37.5, 30.4. ESI HRMS: calcd. for C20H21NO3 + Na 346.1419, found 346.1428.
4-(5-Methoxy-1H-indol-3-yl)-4-(thiophen-2-yl)butan-2-one (4bg). 83% yield. [α]20D +6.2 (c = 0.5, CH2Cl2), 50% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (15% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 19.68 min, tmajor = 17.30 min. 1H NMR (400 MHz, CDCl3): δ = 7.99 (br s, 1H), 7.20 (d, J = 8.8 Hz, 1H), 7.10 (t, J = 3.6 Hz, 1H), 6.99 (d, J = 2.4 Hz, 1H), 6.93 (d, J = 2.0 Hz, 1H), 6.88 (d, J = 3.6 Hz, 2H), 6.83 (dd, J = 8.8, 2.4 Hz, 1H), 5.07 (t, J = 7.6 Hz, 1H), 3.78 (s, 3H), 3.25 (d, J = 7.6 Hz, 2H), 2.09 (S, 3H). 13C NMR (75 MHz, CDCl3): δ = 207.1, 153.9, 148.4, 131.6, 126.5, 124.1, 123.5, 122.2, 118.3, 112.2, 111.9, 101.3, 55.8, 50.8, 33.4, 30.5. ESI HRMS: calcd. for C17H17NO2S + Na 322.0878, found :322.0866.
1-(5-Methoxy-1H-indol-3-yl)-1-phenylpentan-3-one (4be). 91% yield. [α]20D +0.6 (c = 0.5, CH2Cl2), 85% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 37.15 min, tmajor = 20.68 min. 1H NMR (400 MHz, CDCl3): δ = 7.98 (br s, 1H), 7.31–7.14 (m, 6H), 6.93 (d, J = 2.4 Hz, 1H), 6.82–6.78 (m, 2H), 4.79 (t, J = 7.6 Hz, 1H), 3.73 (s, 3H), 3.21 (dd, J = 15.8, 7.6 Hz, 1H), 3.12 (dd, J = 16.0, 8.0 Hz, 1H), 2.41–2.25 (m, 2H), 0.94 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 210.3, 153.7, 144.0, 131.7, 128.4, 127.7, 126.9, 126.3, 122.0, 118.6, 112.1, 111.8, 101.4, 55.8, 49.0, 38.3, 36.5, 7.5. ESI HRMS: calcd. for C20H21NO2 + Na 330.1470, found 330.1461.
1-(4-Chlorophenyl)-1-(5-methoxy-1H-indol-3-yl)pentan-3-one (4bh). 41% yield. [α]20D +13.3 (c = 0.24, CH2Cl2), 88% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 32.79 min, tmajor = 19.02 min. 1H NMR (400 MHz, CDCl3): δ = 7.94 (br s, 1H), 7.25–7.20 (m, 5H), 6.95 (d, J = 2.0 Hz, 1H), 6.82 (dd, J = 13.4, 2.4 Hz, 1H), 6.78 (d, J = 2.4 Hz, 1H), 4.78 (t, J = 7.2 Hz, 3H), 3.75 (s, 3H), 3.20 (dd, J = 16.0, 6.8 Hz, 1H), 3.10 (dd, J = 16.0, 8.0 Hz, 1H), 2.43–2.27 (m, 2H), 0.96 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.8, 153.9, 142.6, 132.0, 131.7, 129.1, 128.5, 126.7, 122.0, 118.3, 112.2, 111.8, 101.4, 55.8, 48.7, 37.6, 36.6, 7.5. ESI HRMS: calcd. for C20H20ClNO2 + Na 364.1080, found 364.1080.
1-(5-Methoxy-1H-indol-3-yl)-1-phenylhexan-3-one (4bi). 78% yield. [α]20D +1.3 (c = 0.38, CH2Cl2), 87% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 31.07 min, tmajor = 17.98 min. 1H NMR (400 MHz, CDCl3): δ = 7.99 (br s, 1H), 7.32–7.24 (m, 4H), 7.20–7.14 (m, 2H), 6.93 (d, J = 2.4 Hz, 1H), 6.83 (d, J = 2.4 Hz, 1H), 6.81 (dd, J = 8.4, 2.4 Hz, 1H), 4.81 (t, J = 7.6 Hz, 1H), 3.74 (s, 3H), 3.20 (dd, J = 16.0, 7.2 Hz, 1H), 3.13 (dd, J = 16.0, 8.0 Hz, 1H), 2.38–2.23 (m, 2H), 1.55–1.46 (m, 2H), 0.80 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.8, 153.7, 144.0, 131.7, 128.4, 127.7, 126.9, 126.3, 122.0, 118.7, 112.1, 111.7, 101.4, 55.8, 49.3, 45.3, 38.2, 16.9, 13.6. ESI HRMS: calcd. for C21H23NO2 + Na 344.1626, found 344.1636.
3-(5-Methoxy-1H-indol-3-yl)cyclohexanone (4bj). 82% yield. [α]20D −1.8 (c = 0.4, CH2Cl2), 56% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 27.97 min, tmajor = 34.58 min. 1H NMR (400 MHz, CDCl3): δ = 8.06 (br s, 1H), 7.25 (d, J = 8.8 Hz, 1H), 7.03 (d, J = 2.4 Hz, 1H), 6.95 (d, J = 2.4 Hz, 1H), 6.87 (dd, J = 8.6, 2.4 Hz, 1H), 3.83 (s, 3H), 3.43–3.36 (m, 1H), 2.82–2.77 (m, 1H), 2.62–2.56 (m, 1H), 2.50–2.36 (m, 2H), 2.28–2.22 (m, 1H), 2.10–2.02 (m, 1H), 1.99–1.77 (m, 2H). 13C NMR (75 MHz, CDCl3): δ = 211.9, 153.8, 131.6, 126.5, 121.1, 119.3, 112.2, 112.0, 100.9, 56.0, 48.0, 41.5, 35.8, 31.5, 24.9. ESI HRMS: calcd. for C15H17NO2 + Na 266.1157, found 266.1148.
4-(5-Bromo-1H-indol-3-yl)heptan-2-one (4ca). 72% yield. [α]20D +4.8 (c = 0.4, CH2Cl2), 59% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (3% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 26.01 min, tmajor = 24.29 min. 1H NMR (400 MHz, CDCl3): δ = 8.21 (br s, 1H), 7.76 (d, J = 1.6 Hz, 1H), 7.26–7.18 (m, 2H), 6.94 (d, J = 2.4 Hz, 1H), 3.43–3.38 (m, 1H), 2.88–2.75 (m, 2H), 2.03 (s, 3H), 1.76–1.61 (m, 2H), 1.27–1.18 (m, 2H), 0.86 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 208.7, 135.1, 128.2, 124.7, 122.5, 121.7, 118.6, 112.7, 112.4, 49.9, 37.9, 32.4, 30.4, 20.7, 14.0. ESI HRMS: calcd. for C15H18BrNO + Na 330.0469, found 330.0461.
4-(2-Methyl-1H-indol-3-yl)heptan-2-one (4da). 99% yield. [α]20D +18.2 (c = 0.34, CH2Cl2), 65% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (5% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 13.90 min, tmajor = 10.83 min. 1H NMR (400 MHz, CDCl3): δ = 7.76 (br s, 1H), 7.59 (d, J = 7.6 Hz, 1H), 7.24 (d, J = 7.2 Hz, 1H), 7.10–7.02 (m, 2H), 3.42–3.34 (m, 1H), 3.04 (dd, J = 13.4, 8.0 Hz, 1H), 2.81 (dd, J = 16.0, 6.0 Hz, 1H), 2.37 (s, 3H), 1.94 (s, 3H), 1.91–1.82 (m, 1H), 1.69–1.61 (m, 1H), 1.26–1.10 (m, 2H), 0.83 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.0, 135.6, 131.4, 127.1, 120.6, 118.9, 118.8, 113.3, 110.4, 49.3, 37.3, 32.4, 30.7, 21.0, 14.0, 12.0. ESI HRMS: calcd. for C16H21NO + Na 266.1521, found 266.1506.
5-Methyl-4-(2-methyl-1H-indol-3-yl)hexan-2-one (4db). 78% yield. [α]20D +35.9 (c = 0.44, CH2Cl2), 82% ee. The enantiomeric excess was determined by HPLC on Chiralpak AD column (10% 2-propanol–hexane, 1 mL min−1), UV 254 nm, tminor = 7.42 min, tmajor = 6.32 min. 1H NMR (400 MHz, CDCl3): δ = 7.73 (br s, 1H), 7.57 (d, J = 7.6 Hz, 1H), 7.24 (d, J = 8.0 Hz, 1H), 7.10–7.01 (m, 2H), 3.14–3.01 (m, 2H), 2.88 (dd, J = 14.4, 3.6 Hz, 1H), 2.36 (s, 3H), 2.20–2.10 (m, 1H), 1.86 (s, 3H), 1.04 (d, J = 6.8 Hz, 3H), 0.72 (d, J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ = 209.5, 135.5, 131.9, 127.3, 120.5, 119.2, 118.8, 113.1, 110.4, 46.7, 40.0, 32.4, 30.7, 21.5, 21.4, 12.1. ESI HRMS: calcd. for C16H21NO + Na 266.1521, found 266.1528.

Acknowledgements

We are grateful for the financial support from the National Natural Science Foundation of China (20502018), Ministry of Education of China (NCET-05-0781) and Fok Ying Tung Education Foundation (101037).

References

  1. For a general review of Friedel–Crafts reactions, see: G. A. Olah, R. Krishnamurti and G. K. S. Prakash, Friedel–Crafts Alkylations, in Comprehensive Organic Synthesis, ed. B. M. Trost and I. Fleming, Pergamon Press, Oxford, 1991, vol. 3, pp. 293–339 Search PubMed.
  2. (a) D. J. Faulkner, Nat. Prod. Rep., 2002, 19, 1 RSC; (b) M. Amat, N. Llor, J. Bosch and X. Solans, Tetrahedron, 1997, 53, 719 CrossRef CAS; (c) A. Kleeman, J. Engel, B. Kutscher and D. Reichert, Pharmaceutical Substances, Thieme, New York, 4th edn, 2001 Search PubMed.
  3. For recent reviews on catalytic asymmetric Friedel–Crafts reactions, see: (a) M. Bandini, A. Melloni, S. Tommasi and A. Umani-Ronchi, Synlett, 2005, 1199 CrossRef CAS; (b) M. Bandini, A. Melloni and A. Umani-Ronchi, Angew. Chem., Int. Ed., 2004, 43, 550 CrossRef CAS; (c) K. A. Jørgensen, Synthesis, 2003, 1117 CrossRef CAS.
  4. (a) K. B. Jensen, J. Thorhauge, R. G. Hazell and K. A. Jørgensen, Angew. Chem., Int. Ed., 2001, 40, 160 CrossRef CAS; (b) J. Zhou and Y. Tang, J. Am. Chem. Soc., 2002, 124, 9030 CrossRef CAS; (c) D. A. Evans, K. A. Scheidt, K. R. Fandrick, H. W. Lam and J. Wu, J. Am. Chem. Soc., 2003, 125, 10780 CrossRef CAS; (d) C. Palomo, M. Oiarbide, B. G. Kardak, J. M. García and A. Linden, J. Am. Chem. Soc., 2005, 127, 4154 CrossRef CAS; (e) D. A. Evans, K. R. Fandrick and H.-J. Song, J. Am. Chem. Soc., 2005, 127, 8942 CrossRef CAS.
  5. (a) M. Bandini, M. Fagioli, P. Melchiorre, A. Melloni and A. Umani-Ronchi, Tetrahedron Lett., 2003, 44, 5846; (b) M. Bandini, M. Fagioli, M. Garavelli, A. Melloni, V. Trigari and A. Umani-Ronchi, J. Org. Chem., 2004, 69, 7511 CrossRef CAS.
  6. (a) N. A. Paras and D. W. C. MacMillan, J. Am. Chem. Soc., 2001, 123, 4370 CrossRef CAS; (b) J. F. Austin and D. W. C. MacMillan, J. Am. Chem. Soc., 2002, 124, 1172 CrossRef CAS; (c) N. A. Paras and D. W. C. MacMillan, J. Am. Chem. Soc., 2002, 124, 7894 CrossRef CAS; (d) J. F. Austin, S.-G. Kim, C. J. Sinz, W.-J. Xiao and D. W. C. MacMillan, Proc. Natl. Acad. Sci. U. S. A., 2004, 101, 5482 CrossRef CAS; (e) H. D. King, Z. Meng, D. Denhart, R. Mattson, R. Kimura, D. Wu, Q. Gao and J. E. Macor, Org. Lett., 2005, 7, 3437 CrossRef CAS.
  7. For recent reviews on organocatalysis, see: (a) P. I. Dalko and L. Moisan, Angew. Chem., Int. Ed., 2004, 43, 5138 CrossRef CAS; (b) Special issue, see: P. I. Dalko and L. Moisan, Acc. Chem. Res., 2004, 37(8) Search PubMed; (c) J. Seayad and B. List, Org. Biomol. Chem., 2005, 3, 719 RSC; (d) B. List, Chem. Commun., 2006, 819 RSC; (e) A. Berkessel and H. Gröger, Asymmetric Organocatalysis, Wiley-VCH, Weinheim, 2005 Search PubMed.
  8. D.-P. Li, Y.-C. Guo, Y. Ding and W.-J. Xiao, Chem. Commun., 2006, 799 RSC.
  9. (a) J.-W. Xie, L. Yue, D. Xue, X.-L. Ma, Y.-C. Chen, Y. Wu, J. Zhu and J.-G. Deng, Chem. Commun., 2006, 1563 RSC; (b) W. Chen, X.-H. Yuan, R. Li, W. Du, Y. Wu, L.-S. Ding and Y.-C. Chen, Adv. Synth. Catal., 2006, 348, 1818 CrossRef CAS.
  10. For asymmetric reactions of α,β-unsaturated ketones catalysed by secondary amines, see: (a) M. Yamaguchi, T. Shiraishi and M. Hirama, J. Org. Chem., 1996, 61, 3520 CrossRef CAS; (b) S. Hanessian and V. Pham, Org. Lett., 2000, 2, 2975 CrossRef CAS; (c) A. B. Northrup and D. W. C. MacMillan, J. Am. Chem. Soc., 2002, 124, 2458 CrossRef CAS; (d) N. Halland, P. S. Aburel and K. A. Jørgensen, Angew. Chem., Int. Ed., 2003, 42, 661 CrossRef CAS; (e) N. Halland, T. Hansen and K. A. Jørgensen, Angew. Chem., Int. Ed., 2003, 42, 4955 CrossRef CAS; (f) N. Halland, P. S. Aburel and K. A. Jørgensen, Angew. Chem., Int. Ed., 2004, 43, 1272 CAS; (g) A. Prieto, N. Halland and K. A. Jørgensen, Org. Lett., 2005, 7, 3897 CrossRef CAS; (h) K. R. Knudsen, C. E. T. Mitchell and S. V. Ley, Chem. Commun., 2006, 66 RSC; (i) J. B. Tuttle, S. G. Ouellet and D. W. C. MacMillan, J. Am. Chem. Soc., 2006, 128, 12662 CrossRef CAS.
  11. For limited examples of primary amines as iminium catalysts, see: for α,β-unsaturated aldehydes (a) K. Ishihara and K. Nakano, J. Am. Chem. Soc., 2005, 127, 10504 CrossRef CAS; (b) A. Sakakura, K. Suzuki, K. Nakano and K. Ishihara, Org. Lett., 2006, 8, 2229 CrossRef CAS; for α,β-unsaturated ketones (c) S. Tsogoeva and S. B. Jagtap, Synlett, 2004, 2624 CrossRef CAS; (d) N. J. A. Martin and B. List, J. Am. Chem. Soc., 2006, 128, 13368 CrossRef CAS; (e) H. Kim, C. Yen, P. Preston and J. Chin, Org. Lett., 2006, 8, 5239 CrossRef CAS.
  12. Y. Xu and A. Córdova, Chem. Commun., 2006, 460 RSC.
  13. H. Brunner, J. Bügler and B. Nuber, Tetrahedron: Asymmetry, 1995, 6, 1699 CrossRef CAS.
  14. For more screening experiments, see Supplementary Information.
  15. The computational studies were conducted with hyperchem 7.5 software (trial edition).
  16. For our recent application of this catalytic system, see: J.-W. Xie, W. Chen, R. Li, M. Zeng, W. Du, L. Yue, Y.-C. Chen, Y. Wu, J. Zhu and J.-G. Deng, Angew. Chem., Int. Ed., 2007, 46, 389 Search PubMed.

Footnotes

Electronic supplementary information (ESI) available: NMR and HPLC spectra of the products. See DOI: 10.1039/b616504d
Crystal data for enantiopure 4bh C20H20ClNO2 (341.82), orthorhombic, space group P212121, a = 5.1480(1), b = 15.8080(3), c = 21.3073(5) Å, U = 1733.98(6) Å3, Z = 4, specimen 0.55 × 0.19 × 0.16 mm3, T = 153(2) K, Mac Science M18XHF22-SRA diffractometer, absorption coefficient 0.232 mm−1, reflections collected/unique 17187/3985 [R(int) = 0.0185], refinement by full-matrix least-squares on F2, data/restraints/parameters 3985/0/224, goodness-of-fit on F2 = 1.008, final R indices [I > 2σ(I)] R1 = 0.0296, wR2 = 0.0778, R indices (all data) R1 = 0.0302, wR2 = 0.0782, absolute structure parameter 0.02(5), extinction coefficient 0.0117(15), largest diff. peak and hole 0.375 and −0.442 e Å−3. CCDC reference number 624251. For crystallographic data in CIF or other electronic format see DOI: 10.1039/b616504d

This journal is © The Royal Society of Chemistry 2007
Click here to see how this site uses Cookies. View our privacy policy here.